Registered entities
Alnara Pharmaceuticals, Inc
Reg. No. 26-2912730United States
Innovation
1 patent family — focus: Human necessities; filing pace dormant. Cited 5 times.
Investor mix
5 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Private equity | 1 | 20% |